Recall of Dimension Apolipoprotein A1

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by DADE BEHRING SA.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
  • Date
  • Event Country
  • Event Source
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    Lot AA0025 of the reagent called Dimension Apolipoprotein A1 reference 7528003 from the company DADE BEHRING SA is withdrawn from the market following the mention of an incorrect expiry date on the labeling (February 2001), not corresponding to the actual expiry date coded by the lot number (25.01.2000). The reagent performances, verified by the manufacturer, being in conformity with those expected, the assays obtained since the 25.01.2000 are not questioned.


  • Model / Serial
  • Product Description
  • Manufacturer


  • Source